Open access · CC-BY
via OpenAlex
Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases
Songling Tang, D. Hao, Wen Ma, Lian Liu, Jiuyu Gao, Peng Yao, Haifang Yu, Lu Gan, Yu Cao
Diabetes & Metabolism Journal · 2024 · ▲ 24 citations
Abstract
Several mitochondrial dysfunctions in obesity and diabetes include impaired mitochondrial membrane potential, excessive mitochondrial reactive oxygen species generation, reduced mitochondrial DNA, increased mitochondrial Ca2+ flux, and mitochondrial dynamics disorders. Mitophagy, specialized autophagy(definition), is responsible for clearing dysfunctional mitochondria in physiological and pathological conditions. As a paradox, inhibition and activation of mitophagy have been observed in obesity and diabetes-related heart disorders, with both exerting bidirectional effects. Suppressed mitophagy is beneficial to mitochondrial homeostasis, also known as benign mitophagy. On the contrary, in most cases, excessive mitophagy is harmful to dysfunctional mitochondria elimination and thus is defined as detrimental mitophagy. In obesity and diabetes, two classical pathways appear to regulate mitophagy, including PTEN-induced putative kinase 1 (PINK1)/Parkin-dependent mitophagy and receptors/adapters-dependent mitophagy. After the pharmacologic interventions of mitophagy, mitochondrial morphology and function have been restored, and cell viability has been further improved. Herein, we summarize the mitochondrial dysfunction(definition) and mitophagy alterations in obesity and diabetes, as well as the underlying upstream mechanisms, in order to provide novel therapeutic strategies for the obesity and diabetes-related heart disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4093/dmj.2023.0213
- Canonical
- link ↗
- Fetched
- 2026-09-21 MST
Cite this
APA
Tang, S., Hao, D., Ma, W., Liu, L., Gao, J., Yao, P., Yu, H., Gan, L., & Cao, Y. (2024). Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases. <em>Diabetes & Metabolism Journal</em>. https://doi.org/10.4093/dmj.2023.0213
Vancouver
Tang S, Hao D, Ma W, Liu L, Gao J, Yao P, et al. Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0213.
BibTeX
@article{songling2024Dysfun,
title = {Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases},
author = {Songling Tang and D. Hao and Wen Ma and Lian Liu and Jiuyu Gao and Peng Yao and Haifang Yu and Lu Gan and Yu Cao},
journal = {Diabetes & Metabolism Journal},
year = {2024},
doi = {10.4093/dmj.2023.0213},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2021
Open access · CC-BY
Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis
Scientific Reports 2019
Open access · CC-BY
Pomegranate activates TFEB to promote autophagy-lysosomal fitness and mitophagy
BioMed Research International 2014
Open access · CC-BY
Mitochondrial Aging and Age-Related Dysfunction of Mitochondria
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
A Healthy Heart and a Healthy Brain: Looking at Mitophagy
Anti-Aging Eastern Europe 2025
Open access · CC-BY
MITOCHONDRIAL THERAPIES IN AGING AND AGE-RELATED DISEASES
Annual Review of Nutrition 2019
Open access · OA